-
Personalized Parkinson Project (PPP)
Data van het Parkinson Op Maat cohort, inclusief klinische data, neuroimaging, biomaterialen en wearable data. -
UroLife study quality of life questionnaire
The EORTC QLQ-C30 and EORTC QLQ-NMIBC24 was completed at 6 weeks (n=1451) and 3 (n=1334), 15 (n=1159) and 51 months (n=588) after diagnosis. -
POM biomaterials
Biomaterials of the Personalized Parkinson Project, including blood, CSF and stool samples. -
PRIDE Study obstetric records
Selected clinical data from obstetric records covering the pregnancy period and puerperium. Necessitates additional consent, provided by ~70% of participants -
ReLife study accelerometer data
Accelerometer data (ActivPal) is available at 3 (n=346), 12 (n=323) and 24 months (n=271) after surgery. -
Continuous Vital Parameters with Clinical Data of Patients Admitted to a...
Vital parameters measured with the VisiMobile (Sotera Wireless; San Diego, CA, USA) of inpatients at Radboudumc (Nijmegen, The Netherlands). The dataset records minute-by-minute... -
ReLife study quality of life questionnaire
The EORTC QLQ-C30 was completed at 3 (n=365), 12 (n=317) and 24 months (n=279) after surgery. -
ReLife study clinical data
Data on tumour characteristics, treatment, complications, recurrence(s), progression and mortality were collected from medical records by data managers of the Netherlands Cancer... -
UroLife study clinical data
Data on tumour characteristics, treatment, and recurrence(s), progression and mortality were collected from medical records by data managers of the Netherlands Cancer Registry... -
ReLife study food frequency questionnaire
A 163-item Food Frequency questionnaire was completed at 3 (n=352), 12 (n=330) and 24 months (n=275) after surgery. -
ReLife study genome-wide germline SNP data
Isolated DNA and genome-wide germline SNP data is available for n=333 patients. -
Tumor sequencing dataset from 17 individuals with biallelic germline...
"This study investigated the molecular landscape of 17 tumors from 9 individuals with biallelic germline pathogenic variants in CHEK2. Tumors included breast and non-breast... -
Whole-exome sequencing of NTHL1 deficient tumors
Whole exome sequencing of 17 tumors from 12 different individuals with biallelic germline NTHL1 mutations from 9 different tissue types. Provided are 17 bam files which are... -
BioCAPTURE registry data
In this ongoing prospective cohort study containing data of 24 Dutch hospitals, patients with psoriasis are asked to be included for the BioCAPTURE registry at the moment of... -
UroLife study molecular subtypes
Molecular subtype based on immunohistrochemistry performed on tissue microarrays is available for 389 T1 NMIBC tumours. -
PRISMA Questionnaire data
The extensive questionnaire covers a number of potential breast cancer risk predictors such as demographics, personal characteristics, reproductive characteristics, medication,... -
POM imaging data
Imaging data of the Personalized Parkinson Project, including structural and functional MRI. -
Pakketadvies dostarlimab (Jemperli) - baarmoederkanker
Zorginstituut adviseert vergoeding voor de aangeduide patiëntengroep; voorwaarden en toepassing in rapport. -
Advies - vergoed deucravacitinib (Sotyktu) voor psoriasis
Zorginstituut adviseert vergoeding (opname in basispakket) voor deze indicatie na afweging van effectiviteit en toepasbaarheid. -
Pakketadvies loncastuximab tesirine (Zynlonta) - lymfeklierkanker
Het Zorginstituut adviseert niet te vergoeden voor de beoordeelde indicatie.
U kunt ook het register raadplegen met behulp van de API (see API documentatie).